Showing results (11-20 of 110) with videos related to
Sort By:
Pageof 11
Future Oncology (London, England)|August 23, 2014
Quizartinib for the treatment of FLT3/ITD acute myeloid leukemiaMark LevisCurrent Opinion in Hematology|January 20, 2011
FLT3 inhibitors: a story of the old and the newAmir Fathi, Mark LevisExpert Opinion on Investigational Drugs|December 4, 2003
Novel FLT3 tyrosine kinase inhibitorsMark Levis, Donald SmallInternational Journal of Hematology|September 9, 2005
FLT3 tyrosine kinase inhibitorsMark Levis, Donald SmallCurrent Pharmaceutical Design|April 14, 2004
Small molecule FLT3 tyrosine kinase inhibitorsMark Levis, Donald SmallExpert Opinion on Therapeutic Targets|September 19, 2014
Targeting FLT3 to treat leukemiaHeiko Konig, Mark LevisHematology/Oncology Clinics of North America|July 5, 2017
Mechanisms of Resistance to FLT3 Inhibitors and the Role of the Bone Marrow MicroenvironmentGabriel Ghiaur, Mark LevisLeukemia & Lymphoma|May 3, 2008
Incorporating FLT3 inhibitors into acute myeloid leukemia treatment regimensKeith Pratz, Mark LevisCurrent Hematologic Malignancy Reports|March 7, 2014
Is targeted therapy feasible in acute myelogenous leukemia?Heiko Konig, Mark LevisHaematologica|July 25, 2020
Potential targeting of FLT3 acute myeloid leukemiaAlexander J Ambinder, Mark LevisPageof 11